159 related articles for article (PubMed ID: 4260342)
1. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
Przegaliński E; Kleinrok Z
Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
[No Abstract] [Full Text] [Related]
2. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
Butcher LL; Engel J; Fuxe K
Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
[No Abstract] [Full Text] [Related]
3. Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats.
Yamori Y; De Jong W; Yamabe H; Lovenberg W; Sjoerdsma A
J Pharm Pharmacol; 1972 Sep; 24(9):690-5. PubMed ID: 4404071
[No Abstract] [Full Text] [Related]
4. Clinical and animal experiments concerning the function of brain catecholamines.
Matussek N
Int Pharmacopsychiatry; 1971; 6(3):170-86. PubMed ID: 4950569
[No Abstract] [Full Text] [Related]
5. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
Gessa GL; Tagliamonte A
Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
[No Abstract] [Full Text] [Related]
6. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
Bartholini G; Blum JE; Pletscher A
J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
[No Abstract] [Full Text] [Related]
7. [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
Gaillard JM; Schaeppi R; Tissot R
Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):423-37. PubMed ID: 5348411
[No Abstract] [Full Text] [Related]
8. The anticonvulsant effect of carbonic anhydrase inhibitors in mice--a noradrenergic mechanism of action.
Torchiana ML; Lotti VJ; Stone CA
Eur J Pharmacol; 1973 Mar; 21(3):343-9. PubMed ID: 4145319
[No Abstract] [Full Text] [Related]
9. Modification of the cardiovascular effects of L-dopa in anesthetized dogs by inhibitors of enzymes involved in catecholamine metabolism.
Robson RD
Circ Res; 1971 Jun; 28(6):662-70. PubMed ID: 4325846
[No Abstract] [Full Text] [Related]
10. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
Ahlenius S
Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
[No Abstract] [Full Text] [Related]
11. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
Seiden LS; Martin TW
Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
[No Abstract] [Full Text] [Related]
12. [Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].
Tissot R
Presse Med (1893); 1969 Apr; 77(17):617-8. PubMed ID: 5785080
[No Abstract] [Full Text] [Related]
13. L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
Antonaccio MJ; Robson RD
Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):89-102. PubMed ID: 4281293
[No Abstract] [Full Text] [Related]
14. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
Viala D; Buser P
Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
[No Abstract] [Full Text] [Related]
15. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
Bartholini G; Da Prada M; Pletscher A
J Pharm Pharmacol; 1968 Mar; 20(3):228-9. PubMed ID: 4385052
[No Abstract] [Full Text] [Related]
16. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
Hsu SY; Huang CL; Waters IW
J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
[TBL] [Abstract][Full Text] [Related]
17. Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.
WEIL-MALHERBE H; POSNER HS; BOWLES GR
J Pharmacol Exp Ther; 1961 Jun; 132():278-86. PubMed ID: 13783846
[No Abstract] [Full Text] [Related]
18. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
Simánĕ Z; Kraus P
Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433
[No Abstract] [Full Text] [Related]
19. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
Andén NE
Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
[No Abstract] [Full Text] [Related]
20. Dopamine: mediator of brain polysome disaggregation after L-dopa.
Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
